Monitoring tests for myeloma after treatment (blood count, kidney function, bone profile, immunoglobulins, protein electrophoresis)
at least every 3 months
tests per year, UK, at least every 3 months
“Monitor myeloma at least every 3 months in people who have completed treatment for the condition and have recovered.”
NICE NG35, Myeloma: diagnosis and management, recommendations, 2016-02
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Smouldering myeloma is also monitored every 3 months for the first 5 years. Monitoring includes full blood count, renal function, bone profile, serum immunoglobulins and protein electrophoresis, and a serum free light chain assay if appropriate. 4 per year is the minimum implied.
Used in
Kept as evidence; no figure on the platform is computed from it yet.